|
| 37503880 | High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experience. | Neuro Oncol | 2024 |
| 37246777 | Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study. | Neuro Oncol | 2023 |
| 37522896 | DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts. | Acta Neuropathol | 2023 |
| 35652336 | Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor. | Neuro Oncol | 2023 |
| 34702771 | Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study. | Clin Cancer Res | 2022 |
| 35545612 | A rare variant analysis framework using public genotype summary counts to prioritize disease-predisposition genes. | Nat Commun | 2022 |
| 35591977 | Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04). | Neurooncol Adv | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 35982322 | Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. | Acta Neuropathol | 2022 |
| 35191090 | The molecular characteristics of low-grade and high-grade areas in desmoplastic infantile astrocytoma/ganglioglioma. | Neuropathol Appl Neurobiol | 2022 |
| 34935967 | Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). | Neuro Oncol | 2022 |
| 34894262 | Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study. | Neuro Oncol | 2022 |
| 35018471 | SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study. | Neuro Oncol | 2022 |
| 34821426 | Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. | Brain Pathol | 2022 |
| 33319313 | Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1. | Acta Neuropathol | 2021 |
| 33879448 | Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas. | Cancer Discov | 2021 |
| 33737307 | Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials. | Clin Cancer Res | 2021 |
| 33502920 | Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. | J Clin Oncol | 2021 |
| 33580238 | Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q. | Neuro Oncol | 2021 |
| 34674998 | Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups. | AJNR Am J Neuroradiol | 2021 |
| 34789196 | The landscape of coding RNA editing events in pediatric cancer. | BMC Cancer | 2021 |
| 34678152 | Serial assessment of measurable residual disease in medulloblastoma liquid biopsies. | Cancer Cell | 2021 |
| 34301788 | Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing. | Cancer Discov | 2021 |
| 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 |
| 34355256 | Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. | Acta Neuropathol | 2021 |
| 33405951 | Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). | J Clin Oncol | 2021 |
| 33141488 | Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. | Brain Pathol | 2021 |
| 33051600 | Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. | Mod Pathol | 2021 |
| 31219344 | Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting. | Arch Pathol Lab Med | 2020 |
| 33506206 | Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial. | Neurooncol Adv | 2020 |
| 32052049 | Risk stratification in pediatric low-grade glioma and glioneuronal tumor treated with radiation therapy: an integrated clinicopathologic and molecular analysis. | Neuro Oncol | 2020 |
| 31867747 | Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14. | Neuropathol Appl Neurobiol | 2020 |
| 31865440 | Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. | Acta Neuropathol | 2020 |
| 31837177 | Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors. | Brain Pathol | 2020 |
| 31802236 | Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. | Acta Neuropathol | 2020 |
| 32100433 | A 4-Year-Old Girl With a Supratentorial Mass. | Brain Pathol | 2020 |
| 31768671 | Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. | Acta Neuropathol | 2020 |
| 31822998 | Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations. | Acta Neuropathol | 2020 |
| 31734728 | YAP1-fusions in pediatric NF2-wildtype meningioma. | Acta Neuropathol | 2020 |
| 32614133 | A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups. | Pediatr Blood Cancer | 2020 |
| 32529709 | Pediatric Posterior Fossa Medulloblastoma: The Role of Diffusion Imaging in Identifying Molecular Groups. | J Neuroimaging | 2020 |
| 32307792 | cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. | Brain Pathol | 2020 |
| 32502305 | cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. | Brain Pathol | 2020 |
| 32243002 | Mini-symposium in medulloblastoma genomics in the modern molecular era. | Brain Pathol | 2020 |
| 32242226 | Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas. | Neuro Oncol | 2020 |
| 32519082 | Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource. | Acta Neuropathol | 2020 |
| 32326973 | Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG. | Acta Neuropathol Commun | 2020 |
| 32238360 | Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes. | Cancer Discov | 2020 |
| 32296180 | Germline Elongator mutations in Sonic Hedgehog medulloblastoma. | Nature | 2020 |